High prevalence but low pathogenicity of hepatitis G virus infection in Italian patients with genetic haemochromatosis

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 5, 1998, Pages 529-533

  De Filippi, F ^a,b,c   Fraquelli, M ^a   Conte, D ^a   Soffredini, R ^a   Prati, D ^a   Ronchi, G ^a   Zanella, A ^a   Del Ninno, E ^a   Colombo, M ^a  

^a Centre for Liver Disease

^b UNIVERSITY OF MILAN   (Italy)

^c Istituto di Medicina Interna   (Italy)

Author keywords

Cryptogenic hepatitis; Genetic haemochromatosis; Hepatitis G virus

Indexed keywords

AMINOTRANSFERASE; BIOCHEMICAL MARKER; HEPATITIS B ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; PRIMER RNA; RECOMBINANT PROTEIN; VIRUS RNA;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD DONOR; BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOCHROMATOSIS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN TISSUE; ITALY; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MOTHER FETUS RELATIONSHIP; PATHOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME;

ADULT; AGE DISTRIBUTION; AGED; BIOLOGICAL MARKERS; BLOOD DONORS; COMORBIDITY; FEMALE; FLAVIVIRIDAE; HEMOCHROMATOSIS; HEPATITIS, VIRAL, HUMAN; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 0031739457     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Niederau C, Fischer R, Purchel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary haemochromatosis. Gastroenterology 1996; 110:1107-19.
2. Bonkovsky HL, Branner BF, Rotham AL. Iron and chronic viral hepatitis. Hepatology 1997;25:759-68.
3. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, et al. Survival and prognostic factors in 212 Italian patients with genetic haemochromatosis. Hepatology 1992;15:655-9.
4. Fargion S, Fracanzani AL, Piperno A, Braga M, D'Alba R, Ronchi G, et al. Prognostics factors for hepatocellular carcinoma in genetic haemochromatosis. Hepatology 1994;20:1426-31.
5. Linnen J, Wage J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
6. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih J\VK, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997:336:747-54.
7. Tameda Y, Kosaka Y, Tagawa S, Takase K, Sawada N, Nakao H, et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol 1996;25:842-7.
8. De Filippi F, Colombo M, Rumi MG, Tradati F, Prati D, Zanella A, et al. High rates of hepatitis G infection in multitransfused patients with hemophilia. Blood 1997;90:4634-7.
9. Prati D, Zanella A, Bosoni P, Rebulla P, Farma E, De Mattei C, et al. The incidence and natural course of transfusion-associated GB virus C/hepatitis G virus infection in a cohort of thalassemic patients. Blood 1998;91:774-7.
10. Tacke M, Schmolke S, Shlueter V, Sauleda S, Esteban JI, Tanaka E, et al. Humoral response to the E2 protein of hepatitis G virus, is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997;26:1626-33.
11. Scheuer PG, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962;84:53-64.
12. Barry M, Sherlock S. Measurements of liver-iron concentration in needle-biopsy specimens. Lancet 1971;i: 100-3.
13. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurement in early haemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-9.
14. Pocock Si. Clinical trials. A practical approach. New York: Wiley and Sons, 1984.